Hoppa till innehåll
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avancerad
  • Systemic review and economic e...
  • Hänvisa
  • Textmeddelande
  • Skicka per e-post
  • Skriv ut
  • Exportera posten
    • Exportera till: RefWorks
    • Exportera till: EndNoteWeb
    • Exportera till: EndNote
  • Permanent länk
Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Bibliografiska uppgifter
Huvudupphovsmän: Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A
Materialtyp: Journal article
Språk:English
Publicerad: 2003
  • Beståndsuppgifter
  • Beskrivning
  • Liknande verk
  • Katalogiseringsuppgifter

Liknande verk

  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    av: Clark, W, et al.
    Publicerad: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    av: Clark, W, et al.
    Publicerad: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
    av: W. Clark, et al.
    Publicerad: (2003-01-01)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    av: Chen, Y, et al.
    Publicerad: (2006)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    av: Chen, Y, et al.
    Publicerad: (2006)

Sökalternativ

  • Sökhistorik
  • Avancerad sökning

Sök mera

  • Bläddra i katalogen
  • Bläddra alfabetiskt
  • Utforska kanaler
  • Kursböcker
  • Nytt i katalogen

Behöver du hjälp?

  • Söktips
  • Fråga biblioteket
  • Vanliga frågor